1. Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models;Tanaka;Oncol Rep,2014
2. Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA;Sakamoto;Int J Oncol,2015
3. A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells;Emura;Int J Mol Med,2004
4. Potentiation of the antitumor activity of α, α, α-trifluorothymidine by the co-administration of an inhibitor of thymidine phosphorylase at a suitable molar ratio in vivo;Emura;Int J Oncol,2005
5. Randomized trial of TAS-102 for refractory metastatic colorectal cancer;Mayer;N Engl J Med,2015